# Piramal Pharma Limited – FDA Inspection, Feb 21, 2017

Source: https://www.keypedia.com/records/fda_inspections/piramal-pharma-limited/4d5108d6-21cc-4fe9-b32e-d5c82096ac34
Source feed: FDA_Inspections

> FDA inspection 1005197 of Piramal Pharma Limited, February 21, 2017. Classification: Voluntary Action Indicated (VAI). Form 483 issued. 8 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1005197
- Company Name: Piramal Pharma Limited
- Inspection Date: 2017-02-21
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1208559 - 2023-05-19
- [FDA Inspection 1103288 - 2019-08-30](https://www.keypedia.com/records/fda_inspections/piramal-pharma-limited/86b06f35-28c9-4f71-bae0-6fefd203f2c6)
- FDA Inspection 1081925 - 2019-01-18
- FDA Inspection 951067 - 2015-10-30
- [FDA Inspection 924411 - 2015-04-03](https://www.keypedia.com/records/fda_inspections/piramal-pharma-limited/19284a5c-c477-4460-8928-1c97b042bde0)

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/daniel-j-roberts/1e1836ac-8bca-4236-a267-33ee0456440c)
- Issuing Officer

Company: https://www.keypedia.com/companies/piramal-pharma-limited/b492136d-42a5-47e3-a443-53373398d2c9

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c